Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Anna Cristina Bertoldi Lemos, Douglas Alexandre do Espírito Santo, Maísa Cabetti Salvetti, et al.
Thrombosis Research (2020) Vol. 196, pp. 359-366
Open Access | Times Cited: 258

Showing 1-25 of 258 citing articles:

Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost, et al.
JAMA (2021) Vol. 325, Iss. 16, pp. 1620-1620
Open Access | Times Cited: 591
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
David Jiménez, Aldara García‐Sánchez, Parth Rali, et al.
CHEST Journal (2020) Vol. 159, Iss. 3, pp. 1182-1196
Open Access | Times Cited: 424
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 3, pp. 872-888
Open Access | Times Cited: 387
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
Waleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 3, pp. e219-e234
Open Access | Times Cited: 360
COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot, Gwilym J. Webb, A. Sidney Barritt, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 5, pp. 348-364
Open Access | Times Cited: 334
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 15, pp. 1903-1921
Open Access | Times Cited: 164
Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, et al.
Journal of the American Heart Association (2020) Vol. 10, Iss. 3
Open Access | Times Cited: 162
ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145
Thromboprophylaxis in Patients With COVID-19
Lisa K. Moores, Tobias Tritschler, Shari B. Brosnahan, et al.
CHEST Journal (2022) Vol. 162, Iss. 1, pp. 213-225
Open Access | Times Cited: 79
Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients
Virginie Montiel, Irina Lobysheva, Ludovic Gérard, et al.
EBioMedicine (2022) Vol. 77, pp. 103893-103893
Open Access | Times Cited: 71
Pharmacology of Heparin and Related Drugs: An Update
John Hogwood, Barbara Mulloy, R. Lever, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 2, pp. 328-379
Open Access | Times Cited: 47
Harnessing the Power of Artificial Intelligence in Pharmaceuticals: Current Trends and Future Prospects
Saha Aritra, Indu Singh
Intelligent Pharmacy (2025)
Open Access | Times Cited: 1
Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis
Eman M. Mansory, Suthan Srigunapalan, Alejandro Lazo‐Langner
TH Open (2021) Vol. 05, Iss. 03, pp. e286-e294
Open Access | Times Cited: 100
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, et al.
Cytokine (2021) Vol. 144, pp. 155593-155593
Open Access | Times Cited: 86
Anticoagulation in COVID-19: current concepts and controversies
Atanu Chandra, Uddalak Chakraborty, Shrestha Ghosh, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1159, pp. 395-402
Open Access | Times Cited: 73
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega‐Paz, Mattía Galli, Davide Capodanno, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2021) Vol. 8, Iss. 7, pp. 677-686
Open Access | Times Cited: 65
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT
Erin A. Bohula, David D. Berg, Mathew S. Lopes, et al.
Circulation (2022) Vol. 146, Iss. 18, pp. 1344-1356
Open Access | Times Cited: 65
Polysulfates Block SARS‐CoV‐2 Uptake through Electrostatic Interactions**
Chuanxiong Nie, Paria Pouyan, Daniel Lauster, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 29, pp. 15870-15878
Open Access | Times Cited: 64
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 20, pp. 3951-3959
Open Access | Times Cited: 58
Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study
Ganeem K. Juneja, Matthew Castelo, Calvin H. Yeh, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 6, pp. 1546-1557
Open Access | Times Cited: 56
Anticoagulants for people hospitalised with COVID-19
Ronald Luiz Gomes Flumignan, Vinicius Tassoni Civile, Jéssica Dantas de Sá Tinôco, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 50
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top